#None #Clinical Trials #ICON #Mural Health

Mural Health and ICON Join Forces to Transform Clinical Trials

In a landmark partnership announced on March 4, 2025, Mural Health Technologies, Inc. and ICON plc have come together to enhance the experience of participants in clinical trials. With Mural Health's reputation as a patient-centric technology company, and ICON's stature as a leading global healthcare intelligence organization, this collaboration promises to revolutionize the approach to clinical trial engagement.

Mural Health has introduced its participant management and payments platform known as Mural Link, which is designed to streamline various administrative functions associated with clinical trials. This platform offers a suite of services including participant payments, tax management, travel and concierge assistance, and advanced site-participant communication tools. Additionally, the platform boasts novel reporting and analytical capabilities that are set to improve efficiency and interaction in clinical trials.

Sam Whitaker, CEO of Mural Health, shared his enthusiasm regarding the partnership: "From our very first conversations with ICON, we were highly impressed by their commitment to patient care and innovation. Our partnership signifies a shared vision of removing barriers to trial participation and advancing financial neutrality for participants, all while alleviating the burden of traditional administration on site staff."

The collaboration aims to eliminate financial obstacles often faced by prospective trial participants. With Mural Health’s innovative payment solutions—including the industry's first fee-free debit card—ICON expects to broaden the pool of recruitable patients. This is particularly significant for historically underrepresented populations, which have traditionally faced substantial challenges in accessing clinical trials.

Dr. Gareth Milborrow, Executive Vice President of Business Operations at ICON, elaborated on the implications of this partnership: "Mural Health's diverse payment methods and unique payment structure, along with a fee-free participant environment, are critical enhancements in how we provide care to patients. We are excited about delivering tangible benefits to both our patients and the sites that serve them."

The partnership is more than just a merging of resources; it represents a commitment to innovate and refine the clinical trial process. With a shared dedication to simplifying participation for patients and caregivers, Mural Health and ICON are setting the stage for a future where clinical trials are more accessible and participant-friendly.

Notably, Mural Health's efforts are steeped in a genuine concern for patient experience. The company aims to redefine the relationship between participants and clinical trials by prioritizing their needs and simplifying the various processes involved. By addressing common pain points associated with clinical trial participation—including coordination of travel, payments, and communication—Mural Health is working to ensure a seamless, engaging, and supportive experience for participants.

As global clinical research continues to evolve, partnerships like the one between Mural Health and ICON can provide the much-needed impetus to drive change. Their combined efforts not only pave the way for a more inclusive approach to clinical trials but also enhance the quality of outcomes through increased patient engagement and satisfaction.

With approximately 41,900 dedicated employees operating in 106 locations across 55 countries, ICON is poised to leverage the insights and enhancements brought forth by Mural Health. Together, these organizations underscore the importance of adaptability and innovation in healthcare, especially in an era where patient experience is paramount.

For more information, please visit Mural Health and ICON.